Seer, Inc. (SEER) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Redwood City, CA, 美国. 现任CEO为 Omid C. Farokhzad.
SEER 拥有 IPO日期为 2020-12-04, 134 名全职员工, 在 NASDAQ Global Select, 市值为 $110.58M.
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
